Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13251
BioCardia
BCDA
$18.6M
| $28.5K | ﹤0.01% |
22,956
-40,428
| -64% | -$42.6K |
|
13252
Origin Agritech
SEED
$11.8M
| $28.3K | ﹤0.01% |
+27,435
| New | +$31.4K |
|
13253
PUT
Fate Therapeutics
FATE
$282M
| $28.1K | ﹤0.01% |
10,400
-16,900
| -62% | -$31.3K |
|
13254
374Water
SCWO
$56.2M
| $28K | ﹤0.01% |
+14,726
| New | +$37.3K |
|
13255
CALL
Westwater Resources
WWR
$69.6M
| $28K | ﹤0.01% |
55,400
-389,300
| -88% | -$231K |
|
13256
Marchex
MCHX
$54.5M
| $27.9K | ﹤0.01% |
17,360
+731
| +4% | +$1.18K |
|
13257
Rapid Micro Biosystems
RPID
$57.7M
| $27.9K | ﹤0.01% |
+16,142
| New | +$34K |
|
13258
Mediaco Holding
MDIA
$88.2M
| $27.9K | ﹤0.01% |
+28,302
| New | +$24K |
|
13259
CALL
BeyondSpring
BYSI
$30.9M
| $27.8K | ﹤0.01% |
+15,900
| New | +$25.7K |
|
13260
CALL
INmune Bio
INMB
$62.7M
| $27.4K | ﹤0.01% |
16,800
+4,300
| +34% | +$5.95K |
|
13261
CALL
AC Immune
ACIU
$266M
| $27.4K | ﹤0.01% |
11,500
-9,400
| -45% | -$25.9K |
|
|
CGC
13262
Canopy Growth
CGC
$389M
| $27.3K | ﹤0.01% |
28,744
-1,102,284
| -97% | -$1.17M |
|
13263
CALL
Rekor Systems
REKR
$60.4M
| $27.2K | ﹤0.01% |
39,100
-46,900
| -55% | -$36.8K |
|
13264
ZK International Group
ZKIN
$69.2M
| $27.1K | ﹤0.01% |
19,254
-3,910
| -17% | -$5.72K |
|
|
SRG
13265
PUT
Seritage Growth Properties
SRG
$113M
| $27.1K | ﹤0.01% |
10,300
-170,400
| -94% | -$448K |
|
13266
CALL
Werewolf Therapeutics
HOWL
$47.6M
| $27K | ﹤0.01% |
+75,000
| New | +$45.7K |
|
13267
Alaunos Therapeutics
TCRT
$3.58M
| $26.8K | ﹤0.01% |
11,870
+1,351
| +13% | +$3.45K |
|
13268
CALL
Playboy Inc
PLBY
$135M
| $26.7K | ﹤0.01% |
21,900
+6,000
| +38% | +$9.1K |
|
|
BGIN
13269
Bgin Blockchain
BGIN
$218M
| $26.6K | ﹤0.01% |
+15,105
| New | +$46K |
|
|
CCUP
13270
CALL
T-REX 2X Long CRCL Daily Target ETF
CCUP
$40.6M
| $26.5K | ﹤0.01% |
1,780
+30
| +2% | +$1.31K |
|
|
COOT
13271
Australian Oilseeds Holdings
COOT
$13.4M
| $26.4K | ﹤0.01% |
+45,422
| New | +$27.9K |
|
|
NXAT
13272
Nexus Advanced Technologies Inc. Ordinary Shares
NXAT
$4.18M
| $26.3K | ﹤0.01% |
+5,908
| New | +$53.8K |
|
|
GLND
13273
CALL
Greenland Energy Co
GLND
$52.5M
| $26K | ﹤0.01% |
+11,800
| New | +$47.5K |
|
|
YDKG
13274
Yueda Digital Holding
YDKG
$4.52M
| $25.8K | ﹤0.01% |
30,328
-41,824
| -58% | -$37.5K |
|
|
CJMB
13275
Callan JMB Inc
CJMB
$13.1M
| $25.8K | ﹤0.01% |
+32,086
| New | +$30.6K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.